M&T Bank Corp Gilead Sciences, Inc. Call Options Transaction History

M&T Bank Corp

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Feb 07, 2022	BUY	$64.88 - $73.64 $4,541 - $5,154	70 Added 75.27%	163 $27,000
Q3 2021 Oct 28, 2021	BUY	$67.69 - $73.03 $5,956 - $6,426	88 Added 1760.0%	93 $9,000
Q4 2019 Feb 07, 2020	SELL	$61.62 - $67.78 $308 - $338	-5 Reduced 50.0%	5 $0
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $312 - $350	5 Added 100.0%	10 $0
Q3 2018 Nov 09, 2018	BUY	$71.28 - $78.92 $142 - $157	2 Added 66.67%	5 $1,000
Q2 2017 Aug 11, 2017	BUY	N/A	3	3 $2,000

1,879

1.02B

12M

8.96M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

Stay updated on M&T Bank Corp with notifications on news.